RIA Novosti informs about it with reference to the RDIF.
The Foundation said that "the country will carry out multicenter, randomized controlled trials, which will include trials for safety and immunogenicity."
RDIF and Dr.
Reddy's agreed in September on a partnership to conduct clinical research on Sputnik V in India.
“We are delighted to be working with regulatory authorities in India and will provide data on the safety and immunogenicity of the vaccine from Phase III trials in Russia, in addition to data from clinical trials in India, to facilitate successful Sputnik V trials in the country,” said the head of the RDIF Kirill Dmitriev.
Earlier, Venezuelan President Nicolas Maduro announced the start of trials in the republic of the Russian vaccine against COVID-19 Sputnik V.